Published in J Dent Res on April 01, 2009
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol (2010) 1.90
Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol (2009) 1.45
Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J (2010) 1.22
Immune suppression in head and neck cancers: a review. Clin Dev Immunol (2011) 1.17
Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med (2010) 1.09
Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci (2013) 1.09
The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agent Cancer (2011) 1.04
Oral Leukoplakia as It Relates to HPV Infection: A Review. Int J Dent (2012) 0.98
Trends in incidence of oral and pharyngeal carcinoma in Florida: 1981-2008. J Public Health Dent (2011) 0.91
Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53. Br J Cancer (2010) 0.91
Contemporary management of cancer of the oral cavity. Eur Arch Otorhinolaryngol (2010) 0.89
Oral and pharyngeal cancer control and early detection. J Cancer Educ (2010) 0.88
History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2011) 0.87
The molecular pathogenesis of head and neck cancer. Cancer Biol Ther (2010) 0.87
Epithelial maturation and molecular biology of oral HPV. Infect Agent Cancer (2009) 0.86
Sequencing the head and neck cancer genome: implications for therapy. Ann N Y Acad Sci (2014) 0.83
Extensive HPV-related carcinoma in situ of the upper aerodigestive tract with 'nonkeratinizing' histologic features. Head Neck Pathol (2013) 0.82
Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals. J Clin Virol (2013) 0.81
Infiltration of m2 tumor-associated macrophages in oral squamous cell carcinoma correlates with tumor malignancy. Cancers (Basel) (2011) 0.81
Dietary fiber and grain consumption in relation to head and neck cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control (2011) 0.78
A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology. J Oral Pathol Med (2013) 0.78
Nonkeratinizing Squamous Cell Carcinoma In Situ of the Upper Aerodigestive Tract: An HPV-Related Entity. Head Neck Pathol (2016) 0.75
Periodontal pocket as a potential reservoir of high risk human papilloma virus: A pilot study. J Indian Soc Periodontol (2016) 0.75
Incidental finding of an extensive oropharyngeal mass in magnetic resonance imaging of a patient with temporomandibular disorder: A case report. Imaging Sci Dent (2016) 0.75
A new risk factor for head and neck squamous cell carcinoma: human papillomavirus. Int J Clin Oncol (2016) 0.75
The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma. Int J Clin Oncol (2016) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (1993) 13.68
Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet (2004) 8.09
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol (2006) 5.86
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst (2000) 5.32
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer (2007) 4.20
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer (2005) 3.79
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis (2004) 3.04
Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol (1991) 2.79
Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev (1995) 2.76
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer (2007) 2.75
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer (2003) 2.69
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene (2006) 2.56
Human papillomavirus (HPV) in head and neck cancer. J Clin Virol (2005) 2.40
Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer (2001) 2.35
Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev (1994) 2.32
Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res (2005) 2.32
Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res (1994) 2.28
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol (2003) 2.26
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer (2003) 2.24
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene (2002) 2.09
The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol (2003) 2.04
Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol (2005) 1.97
Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck (2008) 1.97
Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol (2003) 1.91
Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol (1999) 1.88
Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol (2006) 1.87
Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J (1989) 1.84
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer (2007) 1.80
Human papillomavirus expression in oral mucosa, premalignant conditions, and squamous cell carcinoma: a retrospective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 1.79
Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer (2007) 1.78
Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer (2003) 1.68
Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol (1998) 1.64
Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope (2007) 1.61
Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res (2002) 1.53
Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res (2007) 1.48
Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J (1992) 1.43
Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev (2000) 1.42
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res (2006) 1.37
"High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol (2000) 1.33
Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck (2002) 1.32
Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin Cancer Biol (2003) 1.32
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys (2007) 1.31
Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol (2008) 1.29
Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. Oral Oncol (2002) 1.27
Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev (1996) 1.19
Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2006) 1.17
Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases. Head Neck (2004) 1.17
11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer (2006) 1.14
Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol (2008) 1.13
Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett (2007) 1.07
A transcriptional progression model for head and neck cancer. Clin Cancer Res (2003) 1.06
Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol (1994) 1.06
Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int J Cancer (1996) 1.05
Current status of FDG-PET for head and neck cancer. J Surg Oncol (2008) 0.99
Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med (1991) 0.98
Human papilloma viruses in oral lesions. Anticancer Res (2000) 0.98
Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Vaccine (2006) 0.95
Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg (2008) 0.95
Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacco-associated leukoplakias, and epithelial malignancies. J Oral Maxillofac Surg (1990) 0.94
Occult primary head and neck carcinoma. Curr Oncol Rep (2007) 0.92
The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology (2005) 0.92
Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Anticancer Res (2001) 0.92
Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis. Head Neck (2008) 0.91
Low detection rate of HPV in oral and laryngeal carcinomas. Acta Oncol (1998) 0.85
Human papillomavirus infection in the malignant and premalignant head and neck epithelium. Diagn Mol Pathol (1995) 0.83
Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer (1996) 0.82
Viral gene detection in oral neoplasms using the polymerase chain reaction. Am J Clin Pathol (1993) 0.82
Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg (1998) 0.79
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A (2000) 4.37
Mandatory second opinion surgical pathology at a large referral hospital. Cancer (1999) 3.40
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res (2004) 2.34
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst (1998) 1.78
Serial analysis of gene expression in non-small cell lung cancer. Cancer Res (1998) 1.67
Estimating the costs of substance abuse to the Medicaid hospital care program. Am J Public Health (1995) 1.62
Revealing the link between campaign financing and deaths caused by tobacco. JAMA (1994) 1.61
Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck (2000) 1.51
Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res (2000) 1.46
Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res (2001) 1.39
Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res (1998) 1.39
PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol (1999) 1.36
America's health care revolution: health promotion and disease prevention. J Am Diet Assoc (1987) 1.35
The government-medical education partnership. J Med Educ (1979) 1.34
Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res (2001) 1.34
Intrabiliary growth of metastatic colonic adenocarcinoma: a pattern of intrahepatic spread easily confused with primary neoplasia of the biliary tract. Am J Surg Pathol (1997) 1.33
p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 1.32
Imaging findings of a hibernoma of the neck. AJNR Am J Neuroradiol (2006) 1.28
Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab (2005) 1.27
Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg (2001) 1.22
Molecular genetics of premalignant oral lesions. Oral Dis (2007) 1.21
Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer. J Neurooncol (2013) 1.21
Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res (2000) 1.15
Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst (1999) 1.13
Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol (1999) 1.11
Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literature. Thyroid (2001) 1.11
Allelotype of salivary gland tumors. Cancer Res (1996) 1.10
Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res (1999) 1.09
Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res (1996) 1.08
Occult tonsillar carcinoma in the unknown primary. Laryngoscope (1998) 1.05
Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res (1997) 1.05
Inverted sinonasal papilloma : a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma. Am J Pathol (2000) 1.03
The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth. Oncogene (2007) 1.00
Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res (1999) 1.00
Papillary carcinoma of the thyroid: can operative management be based solely on fine-needle aspiration? J Am Coll Surg (1997) 1.00
The expanding clinical spectrum of desmoplastic small round-cell tumor: a report of two cases with molecular confirmation. Hum Pathol (1999) 0.98
Metastasizing mixed tumor of the parotid: initial presentation as a solitary kidney tumor and ultimate carcinomatous transformation at the primary site. Am J Surg Pathol (2000) 0.98
Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers. Cancer Res (2001) 0.98
Ectopic lingual thyroid masquerading as thyroid cancer metastases. J Clin Endocrinol Metab (2001) 0.97
Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene (1999) 0.97
Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Clin Cancer Res (1997) 0.97
Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer (1998) 0.97
Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res (1999) 0.97
Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Hum Pathol (2002) 0.96
Use of technetium Tc 99m sestamibi scintigraphy for recurrent tertiary hyperparathyroidism from a parathyroid forearm graft. South Med J (2000) 0.96
Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization. Int J Cancer (1997) 0.95
Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene (1999) 0.95
p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol (1998) 0.95
Myosin heavy chain composition in human laryngeal muscles. Laryngoscope (1999) 0.92
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. J Clin Endocrinol Metab (1998) 0.91
Static image analysis of skin specimens: the application of telepathology to frozen section evaluation. Hum Pathol (1997) 0.91
Microsatellite instability in primary neoplasms from HIV + patients. Nat Med (1995) 0.91
Paraganglioma of the thyroid: two cases that clarify and expand the clinical spectrum. Head Neck (2000) 0.89
A putative oncogenic role for MPP11 in head and neck squamous cell cancer. Cancer Res (2000) 0.89
Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst (1991) 0.89
Corticotropin-independent Cushing's syndrome caused by an ectopic adrenal adenoma. J Clin Endocrinol Metab (2000) 0.89
Lymphoid infiltrates of the salivary glands: pathology, biology and clinical significance. Curr Opin Oncol (1996) 0.88
EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer. Eur Respir J (2006) 0.86
Detection of Merkel cell virus and correlation with histologic presence of Merkel cell carcinoma in sentinel lymph nodes. Br J Cancer (2012) 0.86
Bone metastasis from breast carcinoma with fluid-fluid level. Skeletal Radiol (1996) 0.84
Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia. Laryngoscope (1997) 0.84
The health cost of doing business. Health Matrix (1985) 0.84
Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. Clin Cancer Res (1997) 0.83
Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms. Clin Cancer Res (1996) 0.83
Giant cell reparative granuloma of the sphenoid bone. AJNR Am J Neuroradiol (2006) 0.83
Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology (1997) 0.82
Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery (1997) 0.82
Phenotypic and genotypic disparity in premalignant lesions: of calm water and crocodiles. J Natl Cancer Inst (1998) 0.81
Pathologic quiz case 1. Solitary fibrous tumor (SFT) of the orbit. Arch Otolaryngol Head Neck Surg (1996) 0.81
Substance abuse and addiction--the need to know. Am J Public Health (1998) 0.80
Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy. Clin Cancer Res (2001) 0.80
Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer. Arch Otolaryngol Head Neck Surg (1997) 0.80
PSA immunoreactivity in a parotid oncocytoma: a diagnostic pitfall in discriminating primary parotid neoplasms from metastatic prostate cancer. Diagn Cytopathol (1998) 0.79
Two distinct regions of loss on chromosome arm 4q in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2000) 0.79
An allelotype of papillary thyroid cancer. Int J Cancer (1996) 0.79
The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma. Cancer Res (1999) 0.78
School health message. J Sch Health (1977) 0.78
Hypoxic sensitizer and cytotoxin for head and neck cancer. Ann Acad Med Singapore (1996) 0.78
A strategy for future federal support of biomedical research. Clin Res (1978) 0.78
Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia. J Endocrinol Invest (2004) 0.78
HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol (2000) 0.77
Loss of chromosome arms 3p and 9p and inactivation of P16 (INK4a) in normal epithelium of patients with primary lung cancer. Genes Chromosomes Cancer (2001) 0.76
Solitary plasmacytoma of the epiglottis: a case report and review of the literature. J Laryngol Otol (1998) 0.76
Transformation of rat thyroid follicular cells stably transfected with cholera toxin A1 fragment. Endocrinology (1996) 0.76
Sialoblastoma: association with cutaneous hamartoma (organoid nevus)? Pediatr Dev Pathol (2000) 0.76
Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg (1998) 0.75
The wrong way to stay slim. N Engl J Med (1995) 0.75
Preview of Carter's national health plan. US News World Rep (1979) 0.75
Managing the world's largest bureaucracy. OH (1979) 0.75
Comparative microsatellite analysis in discerning origin of disseminated tumor: the case of a patient with malignant ascites and a history of multiple tumors. Hum Pathol (1999) 0.75
Social security and the changing roles of men and women. J Tenn Med Assoc (1979) 0.75
Obstacles to the prevention of teenage smoking. Interview by Alan Blum. N Y State J Med (1985) 0.75
Califano answers back. Interview by Mary Hager. Newsweek (1979) 0.75
Who lives? Who dies? Who pays? America's health care revolution. Vital Speeches Day (1986) 0.75